When tau seeds purified from human AD brain are injected into amyloid mouse model brains, tau spreading, as detected by antibody AT8, positively correlates with the amount of plaques and the degree of neuritic dystrophy around plaques, with AT8 positivity appearing specifically in DNs rather than cell bodies [53, 72, 89]. The gene discussed is MAPT; the disease is amyloidosis.